Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Business intelligence in the global biopharmaceutical sector focuses on drug patent dynamics and the entry of generics. It is essential to forecast future budget needs and proactively seek out generic alternatives. Analyzing the achievements of past patent challengers provides insights into the competitive landscape and informs research directions. This analysis plays a crucial role in guiding portfolio management strategies for upcoming drug development projects. Additionally, anticipating the expiration of patents on branded drugs, pinpointing potential generic suppliers, and managing branded drug inventory effectively are vital. Furthermore, acquiring detailed formulation and manufacturing data helps in identifying key formulators, repackagers, and relabelers to streamline operations and enhance market positioning. Understanding these elements can significantly bolster strategic decision-making in the biopharmaceutical industry.
Description
Scitara DLX™ provides a swift connectivity framework suitable for any instrument found within life science laboratories, all while operating on a cloud-based platform that is both compliant and auditable. As a versatile digital data infrastructure, Scitara DLX™ facilitates connections between various instruments, resources, applications, and software utilized in the lab. The comprehensive cloud system ensures that all data sources are interconnected, promoting seamless data movement across numerous endpoints. Consequently, researchers can concentrate on their scientific endeavors instead of being bogged down by data-related challenges. Moreover, DLX intelligently curates and corrects data as it is processed, fostering the creation of accurate and well-organized data models that are essential for enhancing AI and ML systems. This robust approach plays a vital role in advancing digital transformation strategies within the pharmaceutical and biopharmaceutical sectors. By unlocking valuable insights from scientific data, the platform accelerates decision-making processes in drug discovery and development, ultimately aiding in the expedited launch of new medications into the market. Additionally, the integration of such a sophisticated infrastructure not only streamlines workflows but also enhances collaboration among researchers, paving the way for innovative solutions in the life sciences field.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
$250 per month
Free Trial
No
Free Version
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
DrugPatentWatch
Founded
2003
Country
United States
Website
www.drugpatentwatch.com
Vendor Details
Company Name
Scitara
Founded
2019
Country
United States
Website
scitara.com
Product Features
Product Features
LIMS
Audit Trail
No
Certificates of Analysis
No
Data Import / Export
No
Electronic Laboratory Notebook
No
Inventory Management
No
Lab Instrument Interface
No
Reporting & Statistics
No
Sample Tracking
No
Specification Management
No
Workflow Management
No
Scientific Data Management System (SDMS)
Analytics
No
Artificial Intelligence (AI)
No
Audit
No
Centralized Data Repository
No
Collaboration
No
Compliance
No
Data Security
No
ELN Integration
No
LIMS Integration
No
Workflows
No